Chemotherapy Could Be Covered By Public Health Insurance in All Treatment Centres [interview]
It is possible that cancer treatment may be covered by the community-based health insurance, Mutuelle de Santé, making it more affordable for cancer patients, The New Times has learnt.
Cancer remains a significant threat in
In an interview with Dr Theoneste Maniragaba, Director of the Cancer Programme at Rwanda Biomedical Centre (RBC) and a physician at
Excerpts:
Accessing treatments and medication for cancer can be expensive. Are these costs covered by Mutuelle de Santé?
Cancer treatment is multidisciplinary and involves surgery, radiotherapy, and systemic treatments like chemotherapy and hormonotherapy. Systemic treatment is not covered by
What is the likelihood that, eventually, all cancer treatment will be covered by Mutuelle de Santé?
There are discussions between the Ministry of Health and the
How much does treatment cost, and how does the cost vary depending on the type of cancer?
We can't be sure about the cost for all chemotherapy regimens because it depends on individual procedures, dosage and number of cycles. What can be said is that it ranges between hundreds of thousands and millions of Rwandans francs which is very expensive to be afforded by common Rwandans in reality.
What are the recommended hospitals to go for cancer check-ups or treatment in
Cancer treatment is ensured in teaching and referral hospitals in
What happens to a cancer patient who can't afford cancer treatment?
In most cases, for patients who have reached out to us, we do our best to recommend them so that they can be supported. The problem arises, especially with systemic treatment not available on the Butaro chemotherapy list, which patients cannot afford on their own. However, when the sole treatment to cure them is mandatory, we put ourselves together to support the treatment and save the patient through contributions.
Why is cancer treatment expensive?
It is due to the principle of demand and supply. We think that it is because the pharmaceutical company has to invest a lot to reach the final product. So few of them invest in cancer treatment research and production which doesn't sell like the other treatments such as infectious (HIV/TB/Malaria) and others.
Data-Driven Risk Exchange Accelerant Welcomes Head of Distribution – Europe Gabriella Engstrand
APCIA Applauds Florida Legislature's Commitment to Idalia Recovery & Helping Homeowners Fortify Homes for Future Storms
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News